{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
When is the next results date for Chemcrux Enterprises Ltd?
The next results date for Chemcrux Enterprises Ltd is February 5, 2026.
Chemcrux Enterprises Ltd Falls to 52-Week Low of Rs.91.5 Amid Continued Underperformance
Chemcrux Enterprises Ltd, a player in the Specialty Chemicals sector, recorded a fresh 52-week low of Rs.91.5 today, marking a significant decline in its share price amid broader market pressures and company-specific performance trends.
Chemcrux Enterprises Ltd is Rated Sell
Chemcrux Enterprises Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 06 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 January 2026, providing investors with an up-to-date view of its performance and outlook.
Why is Chemcrux Enterprises Ltd falling/rising?
As of 20-Jan, Chemcrux Enterprises Ltd witnessed a significant decline in its share price, closing at ₹95.80, down ₹5.10 or 5.05%. This drop reflects ongoing challenges faced by the company, including sustained underperformance relative to benchmarks, deteriorating profitability, and subdued investor interest.
Chemcrux Enterprises Ltd Falls to 52-Week Low Amid Continued Underperformance
Shares of Chemcrux Enterprises Ltd, a player in the Specialty Chemicals sector, declined to a fresh 52-week low of Rs.98.15 on 20 Jan 2026, marking a significant drop amid broader market weakness and ongoing company-specific headwinds.
Chemcrux Enterprises Ltd Falls to 52-Week Low of Rs.100 Amid Continued Underperformance
Chemcrux Enterprises Ltd, a player in the Specialty Chemicals sector, has reached a new 52-week low of Rs.100, marking a significant decline in its stock price amid ongoing underperformance relative to market benchmarks and peers.
Chemcrux Enterprises Ltd is Rated Sell
Chemcrux Enterprises Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 06 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 January 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.
Chemcrux Enterprises Ltd is Rated Sell
Chemcrux Enterprises Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 06 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 December 2025, providing investors with the latest insights into its performance and outlook.
Chemcrux Enterp. Sees Revision in Market Evaluation Amidst Challenging Financial Trends
Chemcrux Enterp., a microcap player in the Specialty Chemicals sector, has experienced a revision in its market evaluation reflecting recent changes across key analytical parameters. This shift comes amid persistent financial challenges and subdued stock performance over the past year.
Is Chemcrux Enterp. overvalued or undervalued?
As of November 20, 2025, Chemcrux Enterprises is fairly valued with a PE ratio of 92.25, but has underperformed the Sensex with a year-to-date return of -32.58%, raising concerns about its growth prospects in the specialty chemicals sector.
Is Chemcrux Enterp. overvalued or undervalued?
As of November 7, 2025, Chemcrux Enterprises is overvalued with a PE ratio of 103.22 and low returns, underperforming the Sensex, making it a less attractive investment compared to its peers.
Is Chemcrux Enterp. overvalued or undervalued?
As of November 7, 2025, Chemcrux Enterprises is considered overvalued with a PE ratio of 103.22 and an EV to EBITDA of 16.95, significantly higher than its peers, and has experienced a year-to-date decline of 24.57%, contrasting with the Sensex's gain of 6.50%.
Are Chemcrux Enterp. latest results good or bad?
Chemcrux Enterprises' latest Q2 FY26 results are concerning, with net sales declining slightly and net profit dropping 81.74%, indicating significant operational challenges and declining profitability. The company's margins have contracted, and rising interest costs further exacerbate its financial difficulties.
Chemcrux Enterprises Faces Operational Challenges Amidst Stabilizing Financial Metrics
Chemcrux Enterprises has reported a flat financial performance for the quarter ending September 2025, with a notable shift in its metrics. However, the company faces challenges, particularly a significant decline in profit before tax. Its stock performance has been mixed compared to the Sensex, highlighting ongoing operational difficulties.
How has been the historical performance of Chemcrux Enterp.?
Chemcrux Enterp. has shown a declining trend in financial performance over the past three years, with net sales and profits significantly decreasing while total assets and debt increased. The company has struggled with profitability and cash flow, resulting in a net cash outflow in the latest year.
Why is Chemcrux Enterp. falling/rising?
As of 06-Nov, Chemcrux Enterprises Ltd's stock price is Rs 121.35, down 5.16% and has declined 14.48% over the last three days. The stock shows significant volatility and underperformance compared to the sector, with a year-to-date drop of 28.24% and a year-over-year decline of 39.22%.
Chemcrux Enterprises Q2 FY26: Profit Margins Collapse Amid Rising Interest Burden
Chemcrux Enterprises Ltd., a micro-cap speciality chemicals manufacturer, reported deeply concerning results for Q2 FY26, with net profit plummeting 81.74% year-on-year to ₹0.21 crores from ₹1.15 crores in the corresponding quarter last year. The Vadodara-based company, with a market capitalisation of ₹189 crores, saw its stock price tumble 5.16% following the results announcement, trading at ₹121.35 on November 6, 2025. Despite modest sequential improvement from Q1 FY26's ₹0.09 crores profit, the quarter exposed structural challenges including margin compression, elevated interest costs, and deteriorating profitability that have plagued the company throughout FY26.
Is Chemcrux Enterp. overvalued or undervalued?
As of November 4, 2025, Chemcrux Enterprises is fairly valued with a PE ratio of 68.40, facing challenges with a year-to-date return of -24.33%, and lower profitability metrics compared to peers, indicating the need for close monitoring of its operational efficiency and market conditions.
Is Chemcrux Enterp. overvalued or undervalued?
As of November 4, 2025, Chemcrux Enterprises is fairly valued with a PE Ratio of 68.40, an EV to EBITDA of 24.01, and a Price to Book Value of 2.54, despite a year-to-date decline of 24.33% and a PEG Ratio of 0.00 indicating no growth expectations.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
